Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreas Carcinoma”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Post-approval studies (Phase 4)Looking for participantsNCT06099119
What this trial is testing

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Who this might be right for
Unresectable Pancreatic Cancer
Hospital Clinico Universitario de Santiago 100
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Looking for participantsNCT05841420
What this trial is testing

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerNon-Resectable Pancreas Carcinoma
Morten Ladekarl 98
Not applicableStudy completedNCT04406571
What this trial is testing

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHU de Reims 700
Early research (Phase 1)Study completedNCT01918644
What this trial is testing

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more
University of Wisconsin, Madison 21
Early research (Phase 1)Study completedNCT01385956
What this trial is testing

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)UnknownNCT01728818
What this trial is testing

Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours

Who this might be right for
Focus of Study Instead
PD Dr. med. Volker Heinemann 119
Early research (Phase 1)Ended earlyNCT00658801
What this trial is testing

Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 4
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Large-scale testing (Phase 3)Study completedNCT00416507
What this trial is testing

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 190
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Testing effectiveness (Phase 2)UnknownNCT00690300
What this trial is testing

Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreas Neoplasms
University of Ulm 44
Testing effectiveness (Phase 2)Ended earlyNCT02985801
What this trial is testing

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Massimo Raimondo, M.D. 16
Early research (Phase 1)Study completedNCT00220649
What this trial is testing

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Neoplasms
St. Luke's-Roosevelt Hospital Center 25
Not applicableLooking for participantsNCT06651580
What this trial is testing

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Who this might be right for
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center 1,600
Early research (Phase 1)Study completedNCT00681798
What this trial is testing

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Who this might be right for
Pancreatic Cancer
Sanofi 8
Not applicableLooking for participantsNCT04011982
What this trial is testing

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Who this might be right for
Exocrine Pancreatic Cancer
Centre Leon Berard 300
Not applicableLooking for participantsNCT06422455
What this trial is testing

Access to Genetic Testing in Underserved Patients With Cancer

Who this might be right for
Breast CarcinomaMale Breast CarcinomaMalignant Solid Neoplasm+5 more
University of Southern California 800
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Load More Results